Search results for "DELIVERY SYSTEM"

showing 10 items of 367 documents

Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

2015

Sara Capolla,1 Chiara Garrovo,2 Sonia Zorzet,1 Andrea Lorenzon,3 Enrico Rampazzo,4 Ruben Spretz,5 Gabriele Pozzato,6 Luis Núñez,7 Claudio Tripodo,8 Paolo Macor,1,9 Stefania Biffi2 1Department of Life Sciences, University of Trieste, 2Institute for Maternal and Child Health – IRCCS “Burlo Garofolo”, Trieste, 3Animal Care Unit, Cluster in Biomedicine (CBM scrl), Trieste, Italy; 4Department of Chemistry “G. Ciamician”, University of Bologna, Bologna, Italy; 5LNK Chemsolutions LLC, Lincoln, NE, USA; 6Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy; 7Bio-Target, Inc., University of C…

Medicine (General)Active targeting; Optical imaging; Tumor accumulation; Animals; Antigens CD20; Cell Line Tumor; Humans; Leukemia B-Cell; Mice; Molecular Imaging; Nanoparticles; Polymers; Drug Delivery Systems; Bioengineering; Biophysics; Biomaterials; Drug Discovery3003 Pharmaceutical Science; Organic ChemistryTumor accumulationPolymersPharmaceutical SciencePharmacologyOptical imagingMiceDrug Delivery SystemsNanoparticleInternational Journal of NanomedicineDrug DiscoveryPolymerOriginal ResearchActive targeting; Optical imaging; Tumor accumulation; Animals; Antigens CD20; Cell Line Tumor; Humans; Leukemia B-Cell; Mice; Molecular Imaging; Nanoparticles; Polymers; Drug Delivery Systems; Biophysics; Bioengineering; Biomaterials; Organic Chemistry; Drug Discovery3003 Pharmaceutical ScienceTumorLeukemiaActive targetingtumor accumulationGeneral MedicineMolecular ImagingDrug deliverySystemic administrationPreclinical imagingHumanactive targetingMaterials scienceBiophysicsBioengineeringCell LineBiomaterialsoptical imagingR5-920In vivoCell Line TumormedicineLeukemia B-CellDistribution (pharmacology)AnimalsHumansCD20AntigensAnimalDrug Discovery3003 Pharmaceutical ScienceOrganic ChemistryB-CellCancermedicine.diseaseAntigens CD20BiomaterialTargeted drug deliveryBiophysicNanoparticlesMolecular imagingDrug Delivery System
researchProduct

Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy

2004

The fungal species Candida albicans is an opportunistic pathogen, which causes serious infections in humans, particularly in immunocompromised patients. Depending on the underlying host defect, C. albicans causes a variety of infections, ranging from superficial mucocutaneous candidiasis to life-threatening disseminated infections. Both the limited spectrum of antifungal drugs currently in clinical use and the emergence of resistances make necessary the development of new effective antifungal drugs with minimal side effects; however, such a research is limited by the small number of specific target sites identified to date. The cell wall is a fungal specific dynamic structure essential to a…

Microbiology (medical)Antifungal Agentsmedicine.medical_treatmentCellVirulenceMucocutaneous CandidiasisMicrobiologyDrug Delivery SystemsImmune systemAntigenCell WallDrug Resistance FungalmedicineHumansCandida albicansCandidaPharmacologybiologyCandidiasisImmunotherapybiology.organism_classificationCorpus albicansmedicine.anatomical_structureDrug DesignMolecular MedicineImmunotherapyCurrent Drug Target -Infectious Disorders
researchProduct

Clay-based drug-delivery systems: what does the future hold?

2017

Clays for drug delivery have been used from ancient time due to the large availability of clay minerals and their unprecedented properties. The empirical use of nanoclays from the past is converted in a stimulating scientific task aimed at building up nanoarchitectonic vehicles for drug delivery in a targeted and stimuli-responsive fashion. Here the historical aspects are discussed; next the modern examples of applications of different clay-based materials are discussed. A special focus is given to halloysite clay nanotubes, which are an emerging and very promising nanomaterial for drug-delivery purposes due to its special morphology and unique chemical properties. Advantages and limitatio…

MineralsNanotubesMaterials scienceAncient timePharmaceutical ScienceNanotechnologySettore CHIM/06 - Chimica Organica02 engineering and technologyengineering.material010402 general chemistry021001 nanoscience & nanotechnology01 natural sciencesHalloysite0104 chemical sciencesdrug delivery halloysite nanoclay nanotubesDrug Delivery SystemsDrug deliveryengineeringClayAluminum SilicatesBiochemical engineering0210 nano-technologySettore CHIM/02 - Chimica FisicaTherapeutic Delivery
researchProduct

The gold-sulfur interface at the nanoscale.

2012

Thiolate-protected gold surfaces and interfaces, relevant for self-assembled monolayers of organic molecules on gold, for passivated gold nanoclusters and for molecule-gold junctions, are archetypal systems in various fields of current nanoscience research, materials science, inorganic chemistry and surface science. Understanding this interface at the nanometre scale is essential for a wide range of potential applications for site-specific bioconjugate labelling and sensing, drug delivery and medical therapy, functionalization of gold surfaces for sensing, molecular recognition and molecular electronics, and gold nanoparticle catalysis. During the past five years, considerable experimental …

Models MolecularChemistrySurface PropertiesGeneral Chemical EngineeringNanoparticleMolecular electronicsNanotechnologyStereoisomerismGeneral ChemistryCrystallography X-RayNanoclustersMolecular recognitionDrug Delivery SystemsMonolayerSurface modificationNanotechnologyNanometreGoldSulfhydryl CompoundsNanoscopic scaleSulfurNature chemistry
researchProduct

Controlled release using mesoporous materials containing gate-like scaffoldings.

2009

The use of gated mesoporous silica solids as suitable systems for controlled-release protocols is reviewed. These materials are based on mesoporous silica supports that can be prepared with tailor-made pores of around 2 - 10 nm and that show a very large specific surface area (up to 1200 m(2)/g), thus having a large load capacity. The solids can be additionally functionalised in the external surface with gate-like systems that can be opened on command to allow cargo release. Light, redox reactions, pH, temperature, polarity and enzyme-driven protocols are shown. The possible application in drug delivery protocols is discussed.

Models MolecularDrug CarriersMaterials scienceSilicon dioxidePharmaceutical ScienceNanotechnologyMesoporous silicaSilicon DioxideControlled releaseNanostructureschemistry.chemical_compoundMesoporous organosilicaDrug Delivery SystemschemistrySpecific surface areaDelayed-Action PreparationsMesoporous materialHybrid materialDrug carrierPorosityExpert opinion on drug delivery
researchProduct

Surface Modification of Poly(Vinylchloride) for Manufacturing Advanced Catheters

2017

Polymeric materials, due to their excellent physicochemical properties and versatility found applicability in multiples areas, including biomaterials used in tissue regeneration, prosthetics (hip, artificial valves), medical devices, controlled drug delivery systems, etc. Medical devices and their applications are very important in modern medicine and the need to develop new materials with improved properties or to improve the existent materials is increasing every day. Numerous reasearches are activated in this domain in order to obtain materials/surfaces that does not have drawbacks such as structural failure, calcifications, infections or thrombosis. One of the most used material is pol…

Modern medicineMaterials scienceChemical substanceBiocompatibilityPolymersSurface PropertiesVinyl Chloride030232 urology & nephrologyBiocompatible MaterialsNanotechnology02 engineering and technologySurface finishBiochemistryCatheterization03 medical and health sciencesDrug Delivery Systems0302 clinical medicineDrug DiscoveryPharmacologychemistry.chemical_classificationOrganic ChemistryChemical modificationPolymer021001 nanoscience & nanotechnologychemistryMolecular MedicineSurface modificationWetting0210 nano-technologyCurrent Medicinal Chemistry
researchProduct

A NANOPARTICULATE DRUG-DELIVERY SYSTEM FOR RIVASTIGMINE: PHYSICO-CHEMICAL AND IN VITRO BIOLOGICAL CHARACTERIZATION

2007

The preparation and characterization of surface-PE Gylated polymeric nanoparticles are described. These systems were obtained by UV irradiation of PHM and PHM-PEG(2000) as an inverse microemulsion, using an aqueous solution of the PHM/PHM-PEG(2000) copolymer mixture as the internal phase and triacetin saturated with water as the external phase, and characterized by dimensional analysis, zeta-potential measurements and XPS. in vitro biological tests demonstrated their cell compatibility and their ability to escape from phagocytosis. Rivastigmine was encapsulated into the nanoparticle structure and drug-release profiles from loaded samples were investigated in PBS at pH = 7.4 and human plasma.

Molecular StructureCell SurvivalUltraviolet RaysPhenylcarbamatesRivastigmineHemolysisPolyethylene GlycolsPOLYMERIC NANOPARTICLES RIVASTIGMINE DRUG DELIVERYDrug Delivery SystemsPolymethacrylic AcidsSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoCell Line TumorDelayed-Action PreparationsHumansNanoparticlesPeptidesTriacetin
researchProduct

Nanoparticulate Systems for Drug Delivery and Targeting to the Central Nervous System

2010

Brain delivery is one of the major challenges for the neuropharmaceutical industry since an alarming increase in brain disease incidence is going on. Despite major advances in neuroscience, many potential therapeutic agents are denied access to the central nervous system (CNS) because of the existence of a physiological low permeable barrier, the blood-brain barrier (BBB). To obtain an improvement of drug CNS performance, sophisticated approaches such as nanoparticulate systems are rapidly developing. Many recent data demonstrate that drugs could be transported successfully into the brain using colloidal systems after i.v. injection by several mechanisms such as endocytosis or P-glycoprotei…

Movement disorders/Parkinson’s diseaseDrug CarriersPolymersSurface PropertiesReviewsBrainAlzheimer's diseaseMultiple sclerosisDrug Delivery SystemsMovement disorders/Parkinson's diseaseSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoLiposomesNeuropsychopharmacology.AnimalsHumansNanoparticlesMultiple sclerosiParticle SizeNeuropsychopharmacologyAlzheimer’s diseaseMicellesCentral Nervous System Agents
researchProduct

Multiple Sclerosis: Focus on Extracellular and Artificial Vesicles, Nanoparticles as Potential Therapeutic Approaches

2021

Multiple sclerosis (MS) is an autoimmune disease of the Central Nervous System, characterized by an inflammatory process leading to the destruction of myelin with neuronal death and neurodegeneration. In MS, lymphocytes cross the blood-brain barrier, creating inflammatory demyelinated plaques located primarily in the white matter. MS potential treatments involve various mechanisms of action on immune cells, immunosuppression, inhibition of the passage through the blood-brain barrier, and immunotolerance. Bio-nanotechnology represents a promising approach to improve the treatment of autoimmune diseases by its ability to affect the immune responses. The use of nanotechnology has been actively…

Multiple SclerosisQH301-705.5medicine.medical_treatmentCentral nervous systemInflammationReviewCatalysisInorganic ChemistryMyelinExtracellular VesiclesImmune systemDrug Delivery SystemsMedicinedrug delivery systemAnimalsHumansBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyAutoimmune diseasenanotechnologybusiness.industryMultiple sclerosisOrganic ChemistryNeurodegenerationImmunosuppressionGeneral Medicinemedicine.diseaseComputer Science ApplicationsChemistrymedicine.anatomical_structureinflammationBlood-Brain BarrierLiposomesNanoparticlesmedicine.symptombusinessNeuroscienceImmunosuppressive AgentsimmunotoleranceInternational Journal of Molecular Sciences
researchProduct

Controlled delivery of naltrexone by an intraoral device: in vivo study on human subjects.

2013

Naltrexone is widely used in the treatment of opiate addiction but its current peroral administration is characterized by low bioavailability with various side effects. The development of a long-acting transbuccal delivery device (IntelliDrug) for NLX may be useful to improve patient compliance and the therapy effectiveness. The aims of the study are (a) to test basic safety and effectiveness of controlled transbuccal drug delivery on human subjects; (b) to compare NLX bioavailability following transbuccal delivery vs per os conventional delivery; and (c) to test the hypothesis that transbuccal delivery is more efficient than the conventional route. In this randomized cross-over pilot study…

Naltrexone HydrochlorideAdultMaleAdolescentNarcotic AntagonistsPharmaceutical ScienceAddictionBiological AvailabilityPharmacologySmoking cessationNaltrexonelaw.inventionTransbuccal drug deliveryYoung AdultDrug Delivery SystemsRandomized controlled triallawmedicineHumansNaltrexone hydrochlorideNLXCross-Over Studiesbusiness.industryAdministration BuccalTransmucosal deliveryBuccal administrationMiddle AgedCrossover studyNaltrexoneBioavailabilitySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAnesthesiaDelayed-Action PreparationsDrug deliveryMouth ProtectorsFemalebusinessmedicine.drugInternational journal of pharmaceutics
researchProduct